// immunotherapies

Our R&D Pipeline

01

TriMix
Lipid Nanoparticles
Oncolysis
Tumor microenvironment modulating technology

LEARN MORE
01

Technology

Technology
02

Melanoma
HPV+ cancer
Kidney cancer
Other indications

LEARN MORE
02

Immunostimulation

Immunostimulation
03

eTheRNA is developing mRNA-based products mimicking the action of oncolytic viruses.

LEARN MORE
03

Oncolytic mRNA

Oncolytic mRNA
04

eTheRNA has formed a consortium with North American and European partners to access tools to develop a novel mRNA vaccine against SARS-CoV-2.

LEARN MORE
04

Infectious Disease

Infectious Disease

Galileilaan 19, 2845 Niel, Belgium

Our Address

Our Mailbox

+32 3 369 17 40

Our Phone

© 2020 Etherna | Studio Hanswijk